Calcium channel blockers for pulmonary arterial hypertension-Reference-Cited by-同舟云学术

Calcium channel blockers for pulmonary arterial hypertension

Published:2015-09-25 Issue: Volume: Page:
ISSN:1465-1858
Container-title:Cochrane Database of Systematic Reviews
language:en
Short-container-title:

Author:

Fan Zhiyu¹,Chen Yuanjing²,Liu Hanmin³

Affiliation:

1. Singapore General Hospital; Department of Family Medicine Continuing Care; Outram Road, Singapore Singapore Singapore 169608

2. Singapore General Hospital; Department of Anesthesiology; Singapore General Hospital, Outram Road Singapore Singapore 169608

3. West China Institute of Women’s and Children’s Health, West China Second University Hospital, Sichuan University; Pulmonary Vascular Remodeling Research Unit, Department of Pediatrics; No.20, 3rd Section, Renmin South Road Chengdu Sichuan Province China 610041

Publisher

Wiley

Subject

Pharmacology (medical)

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/14651858.CD010066.pub2/fullpdf

Reference42 articles.

1. Telmisartan improves endothelial function in scleroderma patients with pulmonary hypertension;Yatsyshyn;Journal of Hypertension,2010

2. Rapidly absorbed orodispersible tablet containing molecularly dispersed felodipine for management of hypertensive crisis : development, optimization and in vitro/in vivo studies;Basalious;Pharmaceutical Development and Technology,2013

3. Diltiazem-induced changes in plasma beta-thromboglobulin and platelet aggregation in chronic cor pulmonale;Camerone;La Clinica Terapeutica,1986

4. Independence of oxygen consumption and systemic oxygen transport in patients with either stable pulmonary hypertension or refractory left ventricular failure;Chappell;American Review of Respiratory Disease,1983

5. Hemodynamic and gas exchange effects of intravenous diltiazem in patients with pulmonary hypertension;Crevy;American Journal of Cardiology,1982

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. FUNDC1-mediated mitophagy and HIF1α activation drives pulmonary hypertension during hypoxia;Cell Death & Disease;2022-07-21

2. Biochemical and Proteomic Characterization, and Pharmacological Insights of Indian Red Scorpion Venom Toxins;Frontiers in Pharmacology;2021-09-28

3. Hepatopulmonary Syndrome and Portopulmonary Hypertension: Current Status and Implications for Liver Transplantation;Current Hepatology Reports;2020-07-11

4. Pharmacology of Pulmonary Arterial Hypertension: An Overview of Current and Emerging Therapies;ACS Pharmacology & Translational Science;2020-07-01

5. Correlation of Venom Toxinome Composition of Indian Red Scorpion (Mesobuthus tamulus) with Clinical Manifestations of Scorpion Stings: Failure of Commercial Antivenom to Immune-Recognize the Abundance of Low Molecular Mass Toxins of This Venom;Journal of Proteome Research;2020-03-03